LABA/LAMA combination inhalers (COPD only)
Choice Drug Formulary Choices Anoro Ellipta ®▼ DPI
55/22
(umeclidinium /vilanterol) Or Duaklir Genuair®▼ DPI 340/12 (aclidinium/formoterol)
Or Spiolto Respimat® soft mist 2.5/2.5 inhalation solution (tiotropium/olodaterol)
Or Ultibro Breezhaler® DPI 85/43 inhalation powder capsules with device (indacaterol/glycopyrronium)
| Choice | Drug |
|---|---|
| Formulary Choices | Anoro Ellipta ®▼ DPI 55/22 (umeclidinium /vilanterol) |
| Or | |
Duaklir Genuair®▼ DPI 340/12 (aclidinium/formoterol) | |
| Or | |
Spiolto Respimat® soft mist 2.5/2.5 inhalation solution (tiotropium/olodaterol) | |
| Or | |
Ultibro Breezhaler® DPI 85/43 inhalation powder capsules with device (indacaterol/glycopyrronium) | |
Prescribing Notes
- Consider a LAMA/LABA combination in patients with severe breathlessness symptoms and low risk of exacerbations before considering addition of ICS.
- All LABA/LAMA combination inhalers are less costly than the combined costs of the single inhalers and may be more convenient for patients.